• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global IBS Treatment Market Size, Status and Forecast 2020-2026

report cover
  • 30 July 2020
  • Healthcare
  • 132 Pages
  • Report Code: 24LS-15861
  • Formate :   
Download FREE Report Sample Download PDF File

IBS Treatment -MARKET ADVISORY SERVICES

IBS Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IBS Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Allergan Plc (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals, Inc. (U.S.)
Astellas Pharma Inc. (Japan)
Bausch Health
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals, Inc. (U.S.)
Ardelyx, Inc. (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA, Inc. (Italy)
RedHill Biopharma Ltd. (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Ltd (Japan)
Synthetic Biologics, Inc. (U.S.)
Protagonist Therapeutics Inc. (U.S.)
Pfizer Inc (U.S.)
Lexicon Pharmaceuticals, Inc. (U.S.)
Innovate Biopharmaceuticals (U.S.)

Market segment by Type, the product can be split into
IBS-D
IBS-C
IBS-M
Market segment by Application, split into
Hospitals
Clinics
Research Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IBS Treatment Revenue
1.4 Market by Type
1.4.1 Global IBS Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IBS-D
1.4.3 IBS-C
1.4.4 IBS-M
1.5 Market by Application
1.5.1 Global IBS Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global IBS Treatment Market Perspective (2015-2026)
2.2 Global IBS Treatment Growth Trends by Regions
2.2.1 IBS Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 IBS Treatment Historic Market Share by Regions (2015-2020)
2.2.3 IBS Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 IBS Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key IBS Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top IBS Treatment Players by Market Size
3.1.1 Global Top IBS Treatment Players by Revenue (2015-2020)
3.1.2 Global IBS Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IBS Treatment Market Concentration Ratio
3.2.1 Global IBS Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by IBS Treatment Revenue in 2019
3.3 IBS Treatment Key Players Head office and Area Served
3.4 Key Players IBS Treatment Product Solution and Service
3.5 Date of Enter into IBS Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global IBS Treatment Historic Market Size by Type (2015-2020)
4.2 Global IBS Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global IBS Treatment Market Size by Application (2015-2020)
5.2 Global IBS Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America IBS Treatment Market Size (2015-2020)
6.2 IBS Treatment Key Players in North America (2019-2020)
6.3 North America IBS Treatment Market Size by Type (2015-2020)
6.4 North America IBS Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe IBS Treatment Market Size (2015-2020)
7.2 IBS Treatment Key Players in Europe (2019-2020)
7.3 Europe IBS Treatment Market Size by Type (2015-2020)
7.4 Europe IBS Treatment Market Size by Application (2015-2020)

8 China
8.1 China IBS Treatment Market Size (2015-2020)
8.2 IBS Treatment Key Players in China (2019-2020)
8.3 China IBS Treatment Market Size by Type (2015-2020)
8.4 China IBS Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan IBS Treatment Market Size (2015-2020)
9.2 IBS Treatment Key Players in Japan (2019-2020)
9.3 Japan IBS Treatment Market Size by Type (2015-2020)
9.4 Japan IBS Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia IBS Treatment Market Size (2015-2020)
10.2 IBS Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IBS Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia IBS Treatment Market Size by Application (2015-2020)

11 India
11.1 India IBS Treatment Market Size (2015-2020)
11.2 IBS Treatment Key Players in India (2019-2020)
11.3 India IBS Treatment Market Size by Type (2015-2020)
11.4 India IBS Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America IBS Treatment Market Size (2015-2020)
12.2 IBS Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America IBS Treatment Market Size by Type (2015-2020)
12.4 Central & South America IBS Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Allergan Plc (Ireland)
13.1.1 Allergan Plc (Ireland) Company Details
13.1.2 Allergan Plc (Ireland) Business Overview
13.1.3 Allergan Plc (Ireland) IBS Treatment Introduction
13.1.4 Allergan Plc (Ireland) Revenue in IBS Treatment Business (2015-2020))
13.1.5 Allergan Plc (Ireland) Recent Development
13.2 Sucampo Pharmaceuticals (U.S.)
13.2.1 Sucampo Pharmaceuticals (U.S.) Company Details
13.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
13.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Introduction
13.2.4 Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
13.2.5 Sucampo Pharmaceuticals (U.S.) Recent Development
13.3 Ironwood Pharmaceuticals, Inc. (U.S.)
13.3.1 Ironwood Pharmaceuticals, Inc. (U.S.) Company Details
13.3.2 Ironwood Pharmaceuticals, Inc. (U.S.) Business Overview
13.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
13.3.4 Ironwood Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
13.3.5 Ironwood Pharmaceuticals, Inc. (U.S.) Recent Development
13.4 Astellas Pharma Inc. (Japan)
13.4.1 Astellas Pharma Inc. (Japan) Company Details
13.4.2 Astellas Pharma Inc. (Japan) Business Overview
13.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Introduction
13.4.4 Astellas Pharma Inc. (Japan) Revenue in IBS Treatment Business (2015-2020)
13.4.5 Astellas Pharma Inc. (Japan) Recent Development
13.5 Bausch Health
13.5.1 Bausch Health Company Details
13.5.2 Bausch Health Business Overview
13.5.3 Bausch Health IBS Treatment Introduction
13.5.4 Bausch Health Revenue in IBS Treatment Business (2015-2020)
13.5.5 Bausch Health Recent Development
13.6 Abbott Laboratories (U.S.)
13.6.1 Abbott Laboratories (U.S.) Company Details
13.6.2 Abbott Laboratories (U.S.) Business Overview
13.6.3 Abbott Laboratories (U.S.) IBS Treatment Introduction
13.6.4 Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2015-2020)
13.6.5 Abbott Laboratories (U.S.) Recent Development
13.7 Synergy Pharmaceuticals, Inc. (U.S.)
13.7.1 Synergy Pharmaceuticals, Inc. (U.S.) Company Details
13.7.2 Synergy Pharmaceuticals, Inc. (U.S.) Business Overview
13.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
13.7.4 Synergy Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
13.7.5 Synergy Pharmaceuticals, Inc. (U.S.) Recent Development
13.8 Ardelyx, Inc. (U.S.)
13.8.1 Ardelyx, Inc. (U.S.) Company Details
13.8.2 Ardelyx, Inc. (U.S.) Business Overview
13.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Introduction
13.8.4 Ardelyx, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
13.8.5 Ardelyx, Inc. (U.S.) Recent Development
13.9 Nestle (Switzerland)
13.9.1 Nestle (Switzerland) Company Details
13.9.2 Nestle (Switzerland) Business Overview
13.9.3 Nestle (Switzerland) IBS Treatment Introduction
13.9.4 Nestle (Switzerland) Revenue in IBS Treatment Business (2015-2020)
13.9.5 Nestle (Switzerland) Recent Development
13.10 Sebela Pharmaceuticals (Ireland)
13.10.1 Sebela Pharmaceuticals (Ireland) Company Details
13.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
13.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Introduction
13.10.4 Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2015-2020)
13.10.5 Sebela Pharmaceuticals (Ireland) Recent Development
13.11 Probi (Sweden)
10.11.1 Probi (Sweden) Company Details
10.11.2 Probi (Sweden) Business Overview
10.11.3 Probi (Sweden) IBS Treatment Introduction
10.11.4 Probi (Sweden) Revenue in IBS Treatment Business (2015-2020)
10.11.5 Probi (Sweden) Recent Development
13.12 Alfasigma USA, Inc. (Italy)
10.12.1 Alfasigma USA, Inc. (Italy) Company Details
10.12.2 Alfasigma USA, Inc. (Italy) Business Overview
10.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Introduction
10.12.4 Alfasigma USA, Inc. (Italy) Revenue in IBS Treatment Business (2015-2020)
10.12.5 Alfasigma USA, Inc. (Italy) Recent Development
13.13 RedHill Biopharma Ltd. (Israel)
10.13.1 RedHill Biopharma Ltd. (Israel) Company Details
10.13.2 RedHill Biopharma Ltd. (Israel) Business Overview
10.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Introduction
10.13.4 RedHill Biopharma Ltd. (Israel) Revenue in IBS Treatment Business (2015-2020)
10.13.5 RedHill Biopharma Ltd. (Israel) Recent Development
13.14 AstraZeneca (U.K)
10.14.1 AstraZeneca (U.K) Company Details
10.14.2 AstraZeneca (U.K) Business Overview
10.14.3 AstraZeneca (U.K) IBS Treatment Introduction
10.14.4 AstraZeneca (U.K) Revenue in IBS Treatment Business (2015-2020)
10.14.5 AstraZeneca (U.K) Recent Development
13.15 Ipsen (France)
10.15.1 Ipsen (France) Company Details
10.15.2 Ipsen (France) Business Overview
10.15.3 Ipsen (France) IBS Treatment Introduction
10.15.4 Ipsen (France) Revenue in IBS Treatment Business (2015-2020)
10.15.5 Ipsen (France) Recent Development
13.16 Novartis AG (Switzerland)
10.16.1 Novartis AG (Switzerland) Company Details
10.16.2 Novartis AG (Switzerland) Business Overview
10.16.3 Novartis AG (Switzerland) IBS Treatment Introduction
10.16.4 Novartis AG (Switzerland) Revenue in IBS Treatment Business (2015-2020)
10.16.5 Novartis AG (Switzerland) Recent Development
13.17 Takeda Pharmaceutical Company Ltd (Japan)
10.17.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details
10.17.2 Takeda Pharmaceutical Company Ltd (Japan) Business Overview
10.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Introduction
10.17.4 Takeda Pharmaceutical Company Ltd (Japan) Revenue in IBS Treatment Business (2015-2020)
10.17.5 Takeda Pharmaceutical Company Ltd (Japan) Recent Development
13.18 Synthetic Biologics, Inc. (U.S.)
10.18.1 Synthetic Biologics, Inc. (U.S.) Company Details
10.18.2 Synthetic Biologics, Inc. (U.S.) Business Overview
10.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Introduction
10.18.4 Synthetic Biologics, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.18.5 Synthetic Biologics, Inc. (U.S.) Recent Development
13.19 Protagonist Therapeutics Inc. (U.S.)
10.19.1 Protagonist Therapeutics Inc. (U.S.) Company Details
10.19.2 Protagonist Therapeutics Inc. (U.S.) Business Overview
10.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Introduction
10.19.4 Protagonist Therapeutics Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.19.5 Protagonist Therapeutics Inc. (U.S.) Recent Development
13.20 Pfizer Inc (U.S.)
10.20.1 Pfizer Inc (U.S.) Company Details
10.20.2 Pfizer Inc (U.S.) Business Overview
10.20.3 Pfizer Inc (U.S.) IBS Treatment Introduction
10.20.4 Pfizer Inc (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.20.5 Pfizer Inc (U.S.) Recent Development
13.21 Lexicon Pharmaceuticals, Inc. (U.S.)
10.21.1 Lexicon Pharmaceuticals, Inc. (U.S.) Company Details
10.21.2 Lexicon Pharmaceuticals, Inc. (U.S.) Business Overview
10.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
10.21.4 Lexicon Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.21.5 Lexicon Pharmaceuticals, Inc. (U.S.) Recent Development
13.22 Innovate Biopharmaceuticals (U.S.)
10.22.1 Innovate Biopharmaceuticals (U.S.) Company Details
10.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
10.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Introduction
10.22.4 Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.22.5 Innovate Biopharmaceuticals (U.S.) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. IBS Treatment Key Market Segments

Table 2. Key Players Covered: Ranking by IBS Treatment Revenue

Table 3. Ranking of Global Top IBS Treatment Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global IBS Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of IBS-D

Table 6. Key Players of IBS-C

Table 7. Key Players of IBS-M

Table 8. Global IBS Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 9. Global IBS Treatment Market Size by Regions (US$ Million): 2020 VS 2026

Table 10. Global IBS Treatment Market Size by Regions (2015-2020) (US$ Million)

Table 11. Global IBS Treatment Market Share by Regions (2015-2020)

Table 12. Global IBS Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 13. Global IBS Treatment Market Share by Regions (2021-2026)

Table 14. Market Top Trends

Table 15. Key Drivers: Impact Analysis

Table 16. Key Challenges

Table 17. IBS Treatment Market Growth Strategy

Table 18. Main Points Interviewed from Key IBS Treatment Players

Table 19. Global IBS Treatment Revenue by Players (2015-2020) (Million US$)

Table 20. Global IBS Treatment Market Share by Players (2015-2020)

Table 21. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2019)

Table 22. Global IBS Treatment by Players Market Concentration Ratio (CR5 and HHI)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players IBS Treatment Product Solution and Service

Table 25. Date of Enter into IBS Treatment Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 28. Global IBS Treatment Market Size Share by Type (2015-2020)

Table 29. Global IBS Treatment Revenue Market Share by Type (2021-2026)

Table 30. Global IBS Treatment Market Size Share by Application (2015-2020)

Table 31. Global IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 32. Global IBS Treatment Market Size Share by Application (2021-2026)

Table 33. North America Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 34. North America Key Players IBS Treatment Market Share (2019-2020)

Table 35. North America IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 36. North America IBS Treatment Market Share by Type (2015-2020)

Table 37. North America IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 38. North America IBS Treatment Market Share by Application (2015-2020)

Table 39. Europe Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 40. Europe Key Players IBS Treatment Market Share (2019-2020)

Table 41. Europe IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 42. Europe IBS Treatment Market Share by Type (2015-2020)

Table 43. Europe IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 44. Europe IBS Treatment Market Share by Application (2015-2020)

Table 45. China Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 46. China Key Players IBS Treatment Market Share (2019-2020)

Table 47. China IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 48. China IBS Treatment Market Share by Type (2015-2020)

Table 49. China IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 50. China IBS Treatment Market Share by Application (2015-2020)

Table 51. Japan Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 52. Japan Key Players IBS Treatment Market Share (2019-2020)

Table 53. Japan IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 54. Japan IBS Treatment Market Share by Type (2015-2020)

Table 55. Japan IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 56. Japan IBS Treatment Market Share by Application (2015-2020)

Table 57. Southeast Asia Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 58. Southeast Asia Key Players IBS Treatment Market Share (2019-2020)

Table 59. Southeast Asia IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 60. Southeast Asia IBS Treatment Market Share by Type (2015-2020)

Table 61. Southeast Asia IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 62. Southeast Asia IBS Treatment Market Share by Application (2015-2020)

Table 63. India Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 64. India Key Players IBS Treatment Market Share (2019-2020)

Table 65. India IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 66. India IBS Treatment Market Share by Type (2015-2020)

Table 67. India IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 68. India IBS Treatment Market Share by Application (2015-2020)

Table 69. Central & South America Key Players IBS Treatment Revenue (2019-2020) (Million US$)

Table 70. Central & South America Key Players IBS Treatment Market Share (2019-2020)

Table 71. Central & South America IBS Treatment Market Size by Type (2015-2020) (Million US$)

Table 72. Central & South America IBS Treatment Market Share by Type (2015-2020)

Table 73. Central & South America IBS Treatment Market Size by Application (2015-2020) (Million US$)

Table 74. Central & South America IBS Treatment Market Share by Application (2015-2020)

Table 75. Allergan Plc (Ireland) Company Details

Table 76. Allergan Plc (Ireland) Business Overview

Table 77. Allergan Plc (Ireland) Product

Table 78. Allergan Plc (Ireland) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 79. Allergan Plc (Ireland) Recent Development

Table 80. Sucampo Pharmaceuticals (U.S.) Company Details

Table 81. Sucampo Pharmaceuticals (U.S.) Business Overview

Table 82. Sucampo Pharmaceuticals (U.S.) Product

Table 83. Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 84. Sucampo Pharmaceuticals (U.S.) Recent Development

Table 85. Ironwood Pharmaceuticals, Inc. (U.S.) Company Details

Table 86. Ironwood Pharmaceuticals, Inc. (U.S.) Business Overview

Table 87. Ironwood Pharmaceuticals, Inc. (U.S.) Product

Table 88. Ironwood Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 89. Ironwood Pharmaceuticals, Inc. (U.S.) Recent Development

Table 90. Astellas Pharma Inc. (Japan) Company Details

Table 91. Astellas Pharma Inc. (Japan) Business Overview

Table 92. Astellas Pharma Inc. (Japan) Product

Table 93. Astellas Pharma Inc. (Japan) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 94. Astellas Pharma Inc. (Japan) Recent Development

Table 95. Bausch Health Company Details

Table 96. Bausch Health Business Overview

Table 97. Bausch Health Product

Table 98. Bausch Health Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 99. Bausch Health Recent Development

Table 100. Abbott Laboratories (U.S.) Company Details

Table 101. Abbott Laboratories (U.S.) Business Overview

Table 102. Abbott Laboratories (U.S.) Product

Table 103. Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 104. Abbott Laboratories (U.S.) Recent Development

Table 105. Synergy Pharmaceuticals, Inc. (U.S.) Company Details

Table 106. Synergy Pharmaceuticals, Inc. (U.S.) Business Overview

Table 107. Synergy Pharmaceuticals, Inc. (U.S.) Product

Table 108. Synergy Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 109. Synergy Pharmaceuticals, Inc. (U.S.) Recent Development

Table 110. Ardelyx, Inc. (U.S.) Business Overview

Table 111. Ardelyx, Inc. (U.S.) Product

Table 112. Ardelyx, Inc. (U.S.) Company Details

Table 113. Ardelyx, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 114. Ardelyx, Inc. (U.S.) Recent Development

Table 115. Nestle (Switzerland) Company Details

Table 116. Nestle (Switzerland) Business Overview

Table 117. Nestle (Switzerland) Product

Table 118. Nestle (Switzerland) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 119. Nestle (Switzerland) Recent Development

Table 120. Sebela Pharmaceuticals (Ireland) Company Details

Table 121. Sebela Pharmaceuticals (Ireland) Business Overview

Table 122. Sebela Pharmaceuticals (Ireland) Product

Table 123. Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 124. Sebela Pharmaceuticals (Ireland) Recent Development

Table 125. Probi (Sweden) Company Details

Table 126. Probi (Sweden) Business Overview

Table 127. Probi (Sweden) Product

Table 128. Probi (Sweden) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 129. Probi (Sweden) Recent Development

Table 130. Alfasigma USA, Inc. (Italy) Company Details

Table 131. Alfasigma USA, Inc. (Italy) Business Overview

Table 132. Alfasigma USA, Inc. (Italy) Product

Table 133. Alfasigma USA, Inc. (Italy) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 134. Alfasigma USA, Inc. (Italy) Recent Development

Table 135. RedHill Biopharma Ltd. (Israel) Company Details

Table 136. RedHill Biopharma Ltd. (Israel) Business Overview

Table 137. RedHill Biopharma Ltd. (Israel) Product

Table 138. RedHill Biopharma Ltd. (Israel) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 139. RedHill Biopharma Ltd. (Israel) Recent Development

Table 140. AstraZeneca (U.K) Company Details

Table 141. AstraZeneca (U.K) Business Overview

Table 142. AstraZeneca (U.K) Product

Table 143. AstraZeneca (U.K) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 144. AstraZeneca (U.K) Recent Development

Table 145. Ipsen (France) Company Details

Table 146. Ipsen (France) Business Overview

Table 147. Ipsen (France) Product

Table 148. Ipsen (France) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 149. Ipsen (France) Recent Development

Table 150. Novartis AG (Switzerland) Company Details

Table 151. Novartis AG (Switzerland) Business Overview

Table 152. Novartis AG (Switzerland) Product

Table 153. Novartis AG (Switzerland) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 154. Novartis AG (Switzerland) Recent Development

Table 155. Takeda Pharmaceutical Company Ltd (Japan) Company Details

Table 156. Takeda Pharmaceutical Company Ltd (Japan) Business Overview

Table 157. Takeda Pharmaceutical Company Ltd (Japan) Product

Table 158. Takeda Pharmaceutical Company Ltd (Japan) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 159. Takeda Pharmaceutical Company Ltd (Japan) Recent Development

Table 160. Synthetic Biologics, Inc. (U.S.) Company Details

Table 161. Synthetic Biologics, Inc. (U.S.) Business Overview

Table 162. Synthetic Biologics, Inc. (U.S.) Product

Table 163. Synthetic Biologics, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 164. Synthetic Biologics, Inc. (U.S.) Recent Development

Table 165. Protagonist Therapeutics Inc. (U.S.) Company Details

Table 166. Protagonist Therapeutics Inc. (U.S.) Business Overview

Table 167. Protagonist Therapeutics Inc. (U.S.) Product

Table 168. Protagonist Therapeutics Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 169. Protagonist Therapeutics Inc. (U.S.) Recent Development

Table 170. Pfizer Inc (U.S.) Company Details

Table 171. Pfizer Inc (U.S.) Business Overview

Table 172. Pfizer Inc (U.S.) Product

Table 173. Pfizer Inc (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 174. Pfizer Inc (U.S.) Recent Development

Table 175. Lexicon Pharmaceuticals, Inc. (U.S.) Company Details

Table 176. Lexicon Pharmaceuticals, Inc. (U.S.) Business Overview

Table 177. Lexicon Pharmaceuticals, Inc. (U.S.) Product

Table 178. Lexicon Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 179. Lexicon Pharmaceuticals, Inc. (U.S.) Recent Development

Table 180. Innovate Biopharmaceuticals (U.S.) Company Details

Table 181. Innovate Biopharmaceuticals (U.S.) Business Overview

Table 182. Innovate Biopharmaceuticals (U.S.) Product

Table 183. Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020) (Million US$)

Table 184. Innovate Biopharmaceuticals (U.S.) Recent Development

Table 185. Research Programs/Design for This Report

Table 186. Key Data Information from Secondary Sources

Table 187. Key Data Information from Primary Sources

List of Figures

Figure 1. Global IBS Treatment Market Share by Type: 2020 VS 2026

Figure 2. IBS-D Features

Figure 3. IBS-C Features

Figure 4. IBS-M Features

Figure 5. Global IBS Treatment Market Share by Application: 2020 VS 2026

Figure 6. Hospitals Case Studies

Figure 7. Clinics Case Studies

Figure 8. Research Laboratories Case Studies

Figure 9. IBS Treatment Report Years Considered

Figure 10. Global IBS Treatment Market Size YoY Growth 2015-2026 (US$ Million)

Figure 11. Global IBS Treatment Market Share by Regions: 2020 VS 2026

Figure 12. Global IBS Treatment Market Share by Regions (2021-2026)

Figure 13. Porter's Five Forces Analysis

Figure 14. Global IBS Treatment Market Share by Players in 2019

Figure 15. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2019

Figure 16. The Top 10 and 5 Players Market Share by IBS Treatment Revenue in 2019

Figure 17. North America IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. Europe IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. China IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Japan IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Southeast Asia IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. India IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Central & South America IBS Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Bottom-up and Top-down Approaches for This Report

Figure 25. Data Triangulation

Figure 26. Key Executives Interviewed

Allergan Plc (Ireland)

Sucampo Pharmaceuticals (U.S.)

Ironwood Pharmaceuticals, Inc. (U.S.)

Astellas Pharma Inc. (Japan)

Bausch Health

Abbott Laboratories (U.S.)

Synergy Pharmaceuticals, Inc. (U.S.)

Ardelyx, Inc. (U.S.)

Nestle (Switzerland)

Sebela Pharmaceuticals (Ireland)

Probi (Sweden)

Alfasigma USA, Inc. (Italy)

RedHill Biopharma Ltd. (Israel)

AstraZeneca (U.K)

Ipsen (France)

Novartis AG (Switzerland)

Takeda Pharmaceutical Company Ltd (Japan)

Synthetic Biologics, Inc. (U.S.)

Protagonist Therapeutics Inc. (U.S.)

Pfizer Inc (U.S.)

Lexicon Pharmaceuticals, Inc. (U.S.)

Innovate Biopharmaceuticals (U.S.)

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3198

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase